Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Cancer Research Communications|April 14, 2023
Digital Spatial Profiling Links Beta-2-microglobulin Expression with Immune Checkpoint Blockade Outcomes in Head and Neck Squamous Cell CarcinomaNiki Gavrielatou, Ioannis Vathiotis, Thazin Nwe Aung, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 4, 2021
A new tool for technical standardization of the Ki67 immunohistochemical assayThazin Nwe Aung, Balazs Acs, Jonathan Warrell, et al.
Expert Review of Anticancer Therapy|April 30, 2026
Pembrolizumab trough concentration monitoring and association with outcomes in advanced non-small cell lung cancerIoannis P Trontzas, Anastasia Palaiologou, Natalia Kamperi, et al.
Vaccines|April 23, 2022
Assessment of Seroconversion after SARS-CoV-2 Vaccination in Patients with Lung CancerIoannis P Trontzas, Ioannis Vathiotis, Christina Economidou, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 1, 2022
Discovery of Biomarkers of Resistance to Immune Checkpoint Blockade in NSCLC Using High-Plex Digital Spatial ProfilingMyrto Moutafi, Sandra Martinez-Morilla, Prajan Divakar, et al.
Cancer Gene Therapy|February 13, 2024
Utilizing nullomers in cell-free RNA for early cancer detectionAustin Montgomery, Georgios Christos Tsiatsianis, Ioannis Mouratidis, et al.
BMC Cancer|March 9, 2023
Spatial characterization and quantification of CD40 expression across cancer typesKatherine M Bates, Ioannis Vathiotis, Tyler MacNeil, et al.
Cancer Medicine|June 7, 2024
Predictive capacity of immune-related adverse events and cytokine profiling in neoadjuvant immune checkpoint inhibitor trials for head and neck squamous cell carcinomaAngela E Alnemri, Sruti Tekumalla, Annie E Moroco, et al.
Nature Communications|February 3, 2026
Metabolic characterization of tumor-immune interactions by multiplexed immunofluorescence reveals spatial mechanisms of immunotherapy response in non-small cell lung carcinoma (NSCLC)James Monkman, Aaron Kilgallon, Clara Lawler, et al.
Nature Genetics|October 10, 2025
Spatial signatures for predicting immunotherapy outcomes using multi-omics in non-small cell lung cancerThazin N Aung, James Monkman, Jonathan Warrell, et al.
Pageof 4